Public and Patient Involvement and Engagement (PPIE) refers to the active partnership between patients, carers, the public, and researchers.

Public and Patient Involvement and Engagement

What is PPIE?

Public and Patient Involvement and Engagement (PPIE) refers to the active partnership between patients, carers, the public, and researchers, ensuring that research is shaped with or by people rather than to, about, or for them.

It combines two complementary dimensions that are equally essential, though they serve different purposes across the research ecosystem:

  • Involvement: Active collaboration in research processes. Patients, carers, and the public are equal members of the research team and are involved at all stages of the research life cycle.
  • Engagement: Researchers disseminate knowledge and communicate research implications to the public.

What PPIE is not

Not the same as being a research participant. Research participation means research being conducted on, about, or for patients and the public, where people typically provide samples and/or data as participants in a study.

Not a one‑off consultation. PPIE takes place throughout the research life cycle.

Not tokenistic involvement, for example, when people are invited to join a research advisory group but their views are not listened to or considered when making decisions.

Why it matters?

The key benefits of PPIE are:

01

Ensuring research addresses real-world needs and priorities

02

Improving study design, relevance, and outcomes

03

Strengthening trust, transparency, and accountability

04

Enhancing impact and uptake of research findings

Who is involved?

PPIE aims to be as inclusive as possible and actively seeks to involve a diverse range of people, especially from underrepresented groups. It includes:

Patients and former patients

Carers and families

ionicons-v5-f

People with lived experience of a condition

Communities and patient organisations

How does PPIE work in practice?

PPIE can be embedded across the full research lifecycle:

Priority-setting

Identifying research questions that matter to patients

Dissemination

Co-creating plain-language summaries and outreach activities

Identifying research questions that matter to patients

Co-developing protocols, consent forms, and materials

Participating in advisory boards or steering groups, sometimes getting involved in collecting data (where appropriate)

Providing insight into findings and their meaning

Co-creating plain-language summaries and outreach activities

Study design

Co-developing protocols, consent forms, and materials

Analysis & interpretation

Providing insight into findings and their meaning

Conduct of research

Participating in advisory boards or steering groups, sometimes getting involved in collecting data (where appropriate)

At ERDERA, Public and Patient Involvement and Engagement (PPIE) is embedded as a core, cross‑cutting function across governance and all work packages. People living with rare diseases are placed at the centre of the programme and are involved as co‑designers, implementers, and evaluators of research.

This approach is operationalised through a dedicated PPIE group and ensures that PPIE is not a standalone activity, but a system‑wide practice integrated into governance, funding processes, and research implementation.

Key takeaway

PPIE transforms research from a researcher-driven process into a collaborative partnership, ensuring that science is more relevant, inclusive, and impactful for patients and society.

You might also be interested in

Bringing clinicians, researchers, patient representatives and families together, the event examined how shorter diagnostic pathways depend not only on better tests, but on shared expertise, structured phenotyping and patient-centred support.
Young advocates met in Paris from 23–25 April 2026 for the second ERDERA Training for Young Advocates for Rare Diseases, focused on advocacy, clinical research, patient rights and partnership in paediatric rare disease research.
Two expert‑led facilitation windows linked to EJPRD‑developed MOOCs, give learners the opportunity to engage directly with specialists in health data governance and translational research for rare diseases.
ERDERA interviews Bojana Mirosavljevic, scientist and founder of the Život/Life association in Serbia; and one of the country’s leading voices rare disease patient advocacy.